Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > AGM

<< Previous

Bullboard Posts

Next >>

Comment by ECSINVESTORon Mar 30, 2021 8:24pm

111 Views

Post# 32911378

RE:RE:RE:AGM

Ach. My bad - I keep forgettinmg their year end is Sept 30th... Should be good results based on the continuing organic growth. Wouldn't mind a shoy in the arm from a Plexuss deal.

I only listened to bits and pieces but did they back track from the 400 000 units per week by year end (in their original projections) to 150 000 units per week for VTM? I look at Ontario and they are testing at a rate of 50000+/day. Should be able to suck up whatever Microbix can throw at them....

<< Previous

Bullboard Posts

Next >>

AI companies to invest in